Advertisement

Topics

ERS Genomics and Cellecta, Inc. Sign License Agreement on CRISPR/Cas9 Genome Editing Patents ...

03:06 EST 10 Nov 2017 | BioMedReports - Blog

ERS Genomics:
MacDougall Biomedical Communications
Mario Brkulj or Dr. Stephanie May
Direct: +49 89 2420 9345 or +48 89 2420 9344
mbrkulj@macbiocom.com or smay@macbiocom.com
or
Cellecta:
Cellecta, Inc.
Paul Diehl, 650-938-4050
pauld@cellecta.com
or
Media:
Ruth Mercado, 650-938-4080
rmercado@cellecta.com

Read more...

Original Article: ERS Genomics and Cellecta, Inc. Sign License Agreement on CRISPR/Cas9 Genome Editing Patents ...

NEXT ARTICLE

More From BioPortfolio on "ERS Genomics and Cellecta, Inc. Sign License Agreement on CRISPR/Cas9 Genome Editing Patents ..."

Advertisement
Quick Search
Advertisement
Advertisement